Orphan and paediatric medical devices in Europe: recommendations to support their availability for on-label and off-label clinical indications.

We recommend a more proactive approach to identifying devices at risk and essential devices, increasing the use of exceptional market approvals, expanding the role of expert panels, engaging with the rare disease communities and supporting registries and standards.